CPA
INSP icon

Capital Performance Advisors’s Inspire Medical Systems INSP Stock Holding History

Capital Performance Advisors’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-644
Closed -$136K – 1365
2024
Q3 		$136K Buy
+644
New +$112K 0.04% 150

Other funds holding INSP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Performance Advisors's INSP Position: Q4 2024 in Review

Capital Performance Advisors sold out of Inspire Medical Systems (INSP) in Q4 2024, closing a stake of 644 shares — an estimated $136K sold.

Capital Performance Advisors first reported a position in INSP in Q3 2024 and held it in 1 quarter. The position peaked at $136K in Q3 2024. 357 funds tracked by Wall St. Rank hold INSP as of Q4 2024.

  • Capital Performance Advisors reported no remaining Inspire Medical Systems position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 644 Inspire Medical Systems shares in Q4 2024, an estimated $136K.
  • Capital Performance Advisors first reported a position in Inspire Medical Systems in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's Inspire Medical Systems position peaked at $136K in Q3 2024.
  • 357 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.